CytoDyn (CYDY) Interest & Investment Income (2011 - 2026)
CytoDyn's (CYDY) quarterly Interest & Investment Income came in at $15000.0 in Q1 2026, down 91.33% YoY from $173000.0 in Q1 2025, and down 73.68% on a QoQ basis from $57000.0 in Q4 2025.
Powered by 
Analysis
CytoDyn (CYDY) Interest & Investment Income (2011 - 2026) Analysis & Trends
CytoDyn (CYDY) has 14 years of Interest & Investment Income data on file, last reported at $15000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 91.33% year-over-year to $15000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $290000.0 (down 34.24% YoY) and the FY2025 annual result came in at $565000.0, up 160.37% from the prior year.
- Interest & Investment Income slipped to $15000.0 in Q1 2026, from $57000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $173000.0 in Q1 2025 to a low of $15000.0 in Q1 2026.
- A 3-year average of $104428.6 and a median of $124000.0 in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2025 — Interest & Investment Income dropped 25.4% — and 2026, when it tumbled 91.33%.
- Tracing CYDY's Interest & Investment Income over 3 years: stood at $142000.0 in 2024, then tumbled by 59.86% to $57000.0 in 2025, then tumbled by 73.68% to $15000.0 in 2026.
- The last three Interest & Investment Income figures came in at $15000.0 (Q1 2026), $57000.0 (Q4 2025), and $94000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 10.98 Mn |
| 10 | CytoDyn | 259.28 Mn | 259.28 Mn | - | 91,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 91,000.00 |
| Feb 28, 2026 | 15,000.00 |
| Nov 30, 2025 | 57,000.00 |
| Aug 31, 2025 | 94,000.00 |
| May 31, 2025 | 124,000.00 |
| Feb 28, 2025 | 173,000.00 |
| Nov 30, 2024 | 142,000.00 |
| Aug 31, 2024 | 126,000.00 |
| Feb 28, 2021 | 1,000.00 |
| Feb 29, 2020 | 3,000.00 |
| Nov 30, 2019 | 2,000.00 |
| May 31, 2019 | 1,979.00 |
| Feb 28, 2019 | 19.00 |
| Nov 30, 2018 | 1,021.00 |
| Aug 31, 2018 | 979.00 |
| May 31, 2018 | 1,750.00 |
| Feb 28, 2018 | 662.00 |
| Nov 30, 2017 | 422.00 |
| Aug 31, 2017 | 787.00 |
| May 31, 2017 | 2,196.00 |